Master10
General Science18 Concepts & Facts

Reverse Transcriptase GK Facts, Overview & Study Guide

Reviewed by the Master10 Editorial Board for accuracy, clarity and competitive-exam relevance.Editorial Policy
Reverse Transcriptase (RT)—biochemically classified as RNA-dependent DNA polymerase (EC 2.7.7.49)—is a specialized multifunctional enzyme that catalyzes the synthesis of a complementary double-stranded DNA molecule (cDNA) from a single-stranded RNA template, executing the process of Reverse Transcription (extRNAightarrowextDNAext{RNA} ightarrow ext{DNA}). For nearly two decades after Francis Crick articulated the Central Dogma of Molecular Biology in 1958, prevailing biochemical orthodoxy held that genetic information flows strictly unidirectionally from extDNA→extTranscriptionextRNA→extTranslationextProteinext{DNA} \xrightarrow{ ext{Transcription}} ext{RNA} \xrightarrow{ ext{Translation}} ext{Protein}. That paradigm was shattered in June 1970, when American virologists Howard M. Temin (studying Rous Sarcoma Virus at the University of Wisconsin) and David Baltimore (studying Murine Leukemia Virus at MIT) independently isolated Reverse Transcriptase inside oncogenic RNA tumor viruses—a landmark discovery honoured with the 1975 Nobel Prize in Physiology or Medicine (shared with Renato Dulbecco).

Mechanistically, retroviral Reverse Transcriptase is a three-in-one catalytic nanomachine performing three sequential enzymatic activities inside the host cell cytoplasm: (1) RNA-dependent DNA polymerase activity, which uses a host transfer-RNA (tRNA) primer to transcribe the viral positive-sense single-stranded RNA (+extssRNA+ ext{ssRNA}) genome into an RNA–DNA hybrid duplex; (2) Ribonuclease H (RNase H) activity, an endonuclease domain that selectively degrades the original viral RNA strand from the RNA–DNA hybrid while leaving a small polypurine tract primer; and (3) DNA-dependent DNA polymerase activity, which synthesizes the second complementary DNA strand to form linear double-stranded **proviral DNA (extdsDNAext{dsDNA}). Once transported into the host nucleus, another viral enzyme—Integrase—permanently splices this proviral DNA into the host human chromosome, establishing lifelong latent infection in Retroviruses such as Human Immunodeficiency Virus (HIV-1 and HIV-2).

Crucially, because Reverse Transcriptase completely lacks 3′ightarrow5′3' ightarrow 5' exonuclease proofreading activity**, it exhibits an extraordinarily high mutation error rate (~10−410^{-4} to 10−510^{-5} per base copied—roughly 1,000 times more error-prone than cellular DNA polymerases), explaining why HIV rapidly evolves drug resistance and evades vaccines. In modern biotechnology and clinical medicine, recombinant Reverse Transcriptase is the foundational enzyme driving *RT-PCR (Reverse Transcription–Polymerase Chain Reaction)—the gold-standard diagnostic test used globally to detect RNA viruses (SARS-CoV-2, Ebola, Dengue, Influenza)—and enables geneticists to construct intron-free cDNA libraries for expressing human eukaryotic genes (such as human insulin*) inside bacterial plasmids.

Key Concepts & Self-Assessment18 Key Facts

Review key Reverse Transcriptase exam facts and rate your mastery to track revision.

Progress: 0/18 Rated 0 Mastered 0 Review Later
#1
Biochemical Enzyme Classification: RNA-dependent DNA polymerase (EC 2.7.7.49), capable of synthesizing complementary DNA (cDNA) using an RNA strand as its template.
#2
Co-Discoverers & 1975 Nobel Prize: Independently discovered in June 1970 by Howard M. Temin (with Satoshi Mizutani in Rous Sarcoma Virus) and David Baltimore (in Rauscher Murine Leukemia Virus), earning them the 1975 Nobel Prize in Physiology or Medicine.
#3
Modification of the Central Dogma ('Teminism'): Forced Francis Crick (in a famous 1970 Nature response) to clarify that the Central Dogma permits extRNAightarrowextDNAext{RNA} ightarrow ext{DNA} transfer (Reverse Transcription), forbidding only reverse flow from Protein back to RNA or DNA.
#4
Three Distinct Catalytic Activities in One Enzyme: (1) RNA-dependent DNA polymerase (extRNAightarrowextcDNAext{RNA} ightarrow ext{cDNA}), (2) Ribonuclease H (RNase H) (degrades the RNA strand in an RNA:DNA hybrid), and (3) DNA-dependent DNA polymerase (extssDNAightarrowextdsDNAext{ssDNA} ightarrow ext{dsDNA}).
#5
Absence of 3′ightarrow5′3' ightarrow 5' Proofreading Exonuclease: Unlike cellular replicative DNA polymerases (deltadelta and arepsilonarepsilon), Reverse Transcriptase has **zero 3′ightarrow5′3' ightarrow 5' exonuclease proofreading activity, making ~1 error per 10,000 nucleotides and generating viral quasispecies** in HIV.
#6
Baltimore Virus Classification — Group VI & Group VII: Forms the defining biochemical hallmark of Baltimore Group VI (ssRNA-RT Retroviruses like HIV-1, HTLV-1) and Group VII (dsDNA-RT Pararetroviruses like Hepatitis B Virus [HBV] and Cauliflower Mosaic Virus).
#7
Primer Requirement — Host tRNA: Like all known DNA polymerases, Reverse Transcriptase cannot initiate synthesis de novo; HIV-1 Reverse Transcriptase hijacks the host cell's **exttRNAextLys3ext{tRNA}^{ ext{Lys3}}** molecule as its mandatory 3′3'-OH primer.
#8
Role in RT-PCR Diagnostics (COVID-19 / SARS-CoV-2): Because Taq DNA polymerase in standard PCR can only amplify DNA, diagnosing RNA viruses (like SARS-CoV-2) requires Reverse Transcriptase in Step 1 to convert viral RNA into cDNA before thermal amplification.
#9
Essential Tool for Intron-Free cDNA Cloning (Recombinant Insulin): Bacteria (E. coli) lack spliceosomes and cannot remove eukaryotic introns; geneticists use Reverse Transcriptase on mature spliced mRNA to synthesize intron-free cDNA, allowing bacteria to produce human *Insulin (Humulin) and Factor VIII*.
#10
Endogenous Human Reverse Transcriptase — Telomerase (TERT): Eukaryotic cells possess a specialized native reverse transcriptase called Telomerase (discovered by Elizabeth Blackburn, Carol Greider, and Jack Szostak—2009 Nobel Prize), which uses its own built-in RNA template (TERC) to add extTTAGGGext{TTAGGG} DNA repeats to chromosome ends.
#11
Retrotransposons & the Human Genome (~42% of Human DNA): Nearly 42% of the entire human genome consists of Retrotransposons (such as LINE-1 and Alu elements)—ancient mobile genetic elements copied and pasted across evolution via endogenous reverse transcriptase.
#12
Antiretroviral Drug Class 1 — NRTIs (Chain Terminators): Nucleoside Reverse Transcriptase Inhibitors (NRTIs)—such as Zidovudine (AZT, the first approved HIV drug in 1987), Tenofovir, and Lamivudine—lack a **3′3'-OH group**, terminating viral DNA chain elongation when incorporated by RT.
#13
Antiretroviral Drug Class 2 — NNRTIs (Allosteric Blockers): Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)—such as Nevirapine and Efavirenz—bind directly to a hydrophobic pocket near the RT active site, locking the enzyme's conformation without competing with nucleotides.
#14
First Transition to Modern Dolutegravir (TLD) Regimen under NACO: India's National AIDS Control Organisation (NACO) standard first-line TLD regimen combines two NRTIs (Tenofovir + Lamivudine) targeting Reverse Transcriptase with one Integrase Strand Transfer Inhibitor (Dolutegravir).
#15
Commercial Laboratory Sources of RT: Molecular biology kits use recombinant M-MLV RT (Moloney Murine Leukemia Virus, a monomeric enzyme) or AMV RT (Avian Myeloblastosis Virus, a more thermostable heterodimer).
#16
Structural Architecture of HIV-1 Reverse Transcriptase: An asymmetric heterodimer comprising a p66 subunit (560 amino acids containing the polymerase fingers/palm/thumb and RNase H domains) and a proteolytic p51 subunit (440 amino acids providing structural scaffold).
#17
Bacterial Retrons & CRISPR Prime Editing (Anzalone & Liu, 2019): Next-generation CRISPR Prime Editing fuses a Cas9 nickase directly to an engineered Reverse Transcriptase, using a pegRNA template to 'search-and-replace' single-base genetic disease mutations in human cells without double-strand DNA breaks.
#18
Discovery of Hepatitis B Reverse Transcription (Summers & Mason, 1982): Proved that even though Hepatitis B Virus (HBV) packages a partially double-stranded DNA genome, it replicates through an *RNA intermediate (pregenomic RNA) using viral Reverse Transcriptase—explaining why HIV NRTI drugs like Tenofovir and Entecavir* also treat chronic Hepatitis B.

Subject Specialist Commentary

Analytical perspective & practical exam advice from the Master10 academic board

Educator's Insight
Before 1970, biology textbooks taught that genetic instructions only flowed one way: from DNA to RNA to Protein. Howard Temin and David Baltimore overturned that rule by discovering Reverse Transcriptase—an enzyme carried by Retroviruses (like HIV) that reads an RNA strand and writes a double-stranded DNA copy (cDNA) so the virus can splice itself permanently into human chromosomes.
In UPSC Prelims and Science exams, Reverse Transcriptase connects three high-yield exam questions: (1) Why is RT needed in RT-PCR for COVID-19/Nipah? Because standard PCR (Taq polymerase) can only copy DNA, so viral RNA must first be converted into cDNA by Reverse Transcriptase; (2) Why does HIV mutate so fast? Because Reverse Transcriptase completely **lacks 3′ightarrow5′3' ightarrow 5' proofreading activity; and (3) Why do HIV drugs like Tenofovir also work against Hepatitis B? Because Hepatitis B (a DNA pararetrovirus)** also uses Reverse Transcriptase during replication!

Related Knowledge Topics to Discover

Looking for more GK practice?

Explore 52,789+ questions across 65 General Knowledge categories.

Open Interactive Search